ULTRATRACE Iobenguane I 131 in Patients With Malignant Pheochromocytoma, Paraganglioma, or Metastatic Carcinoid

NCT00339131 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Pheochromocytoma
Paraganglioma
Carcinoid

Interventions

DRUG: Ultratrace iobenguane I 131

Sponsor

Molecular Insight Pharmaceuticals, Inc.